

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protoporphyrinogen IX metabolic process (GO:0046501) | 5.05291846 |
| 2 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 4.71214086 |
| 3 | negative regulation of cell killing (GO:0031342) | 4.57882172 |
| 4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.57882172 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 4.48655149 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 4.48655149 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.48655149 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.48655149 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.48655149 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 4.48655149 |
| 11 | cellular extravasation (GO:0045123) | 4.45399360 |
| 12 | detection of molecule of bacterial origin (GO:0032490) | 4.17392260 |
| 13 | valine metabolic process (GO:0006573) | 4.14993920 |
| 14 | microglial cell activation (GO:0001774) | 4.13264220 |
| 15 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.09827854 |
| 16 | alpha-linolenic acid metabolic process (GO:0036109) | 4.09474531 |
| 17 | neutrophil activation (GO:0042119) | 4.02157957 |
| 18 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.94770409 |
| 19 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.90963312 |
| 20 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.88396600 |
| 21 | regulation of platelet aggregation (GO:0090330) | 3.87971566 |
| 22 | detection of other organism (GO:0098543) | 3.87807381 |
| 23 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.81228933 |
| 24 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.81228933 |
| 25 | granulocyte activation (GO:0036230) | 3.69404822 |
| 26 | response to peptidoglycan (GO:0032494) | 3.68258891 |
| 27 | cysteine metabolic process (GO:0006534) | 3.67258205 |
| 28 | detection of external biotic stimulus (GO:0098581) | 3.65490086 |
| 29 | macrophage activation involved in immune response (GO:0002281) | 3.65227444 |
| 30 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.65004148 |
| 31 | sulfur amino acid catabolic process (GO:0000098) | 3.64475542 |
| 32 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.59957230 |
| 33 | regulation of triglyceride catabolic process (GO:0010896) | 3.59272975 |
| 34 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.57953897 |
| 35 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.57953897 |
| 36 | positive regulation of mast cell activation (GO:0033005) | 3.57146413 |
| 37 | regulation of gamma-delta T cell activation (GO:0046643) | 3.57097781 |
| 38 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.53582885 |
| 39 | L-phenylalanine catabolic process (GO:0006559) | 3.53582885 |
| 40 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.51016864 |
| 41 | plasma lipoprotein particle assembly (GO:0034377) | 3.50256404 |
| 42 | regulation of mast cell degranulation (GO:0043304) | 3.49171531 |
| 43 | urea cycle (GO:0000050) | 3.48913383 |
| 44 | urea metabolic process (GO:0019627) | 3.48913383 |
| 45 | lysine metabolic process (GO:0006553) | 3.45630879 |
| 46 | lysine catabolic process (GO:0006554) | 3.45630879 |
| 47 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.44171600 |
| 48 | macrophage activation (GO:0042116) | 3.41823220 |
| 49 | detection of bacterium (GO:0016045) | 3.41650707 |
| 50 | pentose-phosphate shunt (GO:0006098) | 3.41557683 |
| 51 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.39596201 |
| 52 | L-phenylalanine metabolic process (GO:0006558) | 3.36367893 |
| 53 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.36367893 |
| 54 | positive regulation of B cell differentiation (GO:0045579) | 3.34742144 |
| 55 | neutrophil mediated immunity (GO:0002446) | 3.32878920 |
| 56 | response to host immune response (GO:0052572) | 3.32471385 |
| 57 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.32471385 |
| 58 | NADPH regeneration (GO:0006740) | 3.32367873 |
| 59 | myeloid cell activation involved in immune response (GO:0002275) | 3.26019164 |
| 60 | negative regulation of interleukin-12 production (GO:0032695) | 3.24364403 |
| 61 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.23851910 |
| 62 | regulation of platelet activation (GO:0010543) | 3.23777234 |
| 63 | reverse cholesterol transport (GO:0043691) | 3.22496390 |
| 64 | protein-lipid complex assembly (GO:0065005) | 3.22471664 |
| 65 | phospholipid efflux (GO:0033700) | 3.19412259 |
| 66 | high-density lipoprotein particle remodeling (GO:0034375) | 3.19004988 |
| 67 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.18815049 |
| 68 | aromatic amino acid family catabolic process (GO:0009074) | 3.18448745 |
| 69 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.18228643 |
| 70 | nitrogen cycle metabolic process (GO:0071941) | 3.16795655 |
| 71 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.16403646 |
| 72 | complement activation, alternative pathway (GO:0006957) | 3.15665395 |
| 73 | amino-acid betaine metabolic process (GO:0006577) | 3.14716192 |
| 74 | detection of biotic stimulus (GO:0009595) | 3.14682828 |
| 75 | plasma lipoprotein particle remodeling (GO:0034369) | 3.14251077 |
| 76 | protein-lipid complex remodeling (GO:0034368) | 3.14251077 |
| 77 | macromolecular complex remodeling (GO:0034367) | 3.14251077 |
| 78 | regulation of leukocyte degranulation (GO:0043300) | 3.10984048 |
| 79 | phospholipid homeostasis (GO:0055091) | 3.10608940 |
| 80 | megakaryocyte development (GO:0035855) | 3.10102630 |
| 81 | plasma lipoprotein particle organization (GO:0071827) | 3.09496196 |
| 82 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.08495184 |
| 83 | heme biosynthetic process (GO:0006783) | 3.07224372 |
| 84 | hepatocyte apoptotic process (GO:0097284) | 3.06747193 |
| 85 | regulation of mast cell activation (GO:0033003) | 3.05629886 |
| 86 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.05602465 |
| 87 | response to host (GO:0075136) | 3.05602465 |
| 88 | response to host defenses (GO:0052200) | 3.05602465 |
| 89 | B cell receptor signaling pathway (GO:0050853) | 3.03337387 |
| 90 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.02696324 |
| 91 | positive regulation of granulocyte differentiation (GO:0030854) | 3.02561397 |
| 92 | glyoxylate metabolic process (GO:0046487) | 3.02292929 |
| 93 | porphyrin-containing compound biosynthetic process (GO:0006779) | 3.01718600 |
| 94 | respiratory burst (GO:0045730) | 2.99112796 |
| 95 | 2-oxoglutarate metabolic process (GO:0006103) | 2.98258261 |
| 96 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.97793767 |
| 97 | low-density lipoprotein particle remodeling (GO:0034374) | 2.97491671 |
| 98 | protein-lipid complex subunit organization (GO:0071825) | 2.95992812 |
| 99 | leukocyte degranulation (GO:0043299) | 2.95276894 |
| 100 | cholesterol efflux (GO:0033344) | 2.94837253 |
| 101 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.91738800 |
| 102 | protein carboxylation (GO:0018214) | 2.91738800 |
| 103 | bile acid biosynthetic process (GO:0006699) | 2.91477733 |
| 104 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.91421423 |
| 105 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.90698880 |
| 106 | tryptophan metabolic process (GO:0006568) | 2.90069286 |
| 107 | ethanol oxidation (GO:0006069) | 2.89366338 |
| 108 | plasma lipoprotein particle clearance (GO:0034381) | 2.89121358 |
| 109 | killing of cells of other organism (GO:0031640) | 2.88304035 |
| 110 | disruption of cells of other organism (GO:0044364) | 2.88304035 |
| 111 | regulation of protein activation cascade (GO:2000257) | 2.88285969 |
| 112 | tryptophan catabolic process (GO:0006569) | 2.86989846 |
| 113 | indole-containing compound catabolic process (GO:0042436) | 2.86989846 |
| 114 | indolalkylamine catabolic process (GO:0046218) | 2.86989846 |
| 115 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.86820284 |
| 116 | heme metabolic process (GO:0042168) | 2.86329962 |
| 117 | positive regulation of receptor recycling (GO:0001921) | 2.84380893 |
| 118 | kynurenine metabolic process (GO:0070189) | 2.84267205 |
| 119 | tricarboxylic acid metabolic process (GO:0072350) | 2.84039912 |
| 120 | negative regulation of interleukin-17 production (GO:0032700) | 2.83573211 |
| 121 | homocysteine metabolic process (GO:0050667) | 2.82727623 |
| 122 | fatty acid beta-oxidation (GO:0006635) | 2.82000461 |
| 123 | angiotensin maturation (GO:0002003) | 2.81354719 |
| 124 | low-density lipoprotein particle clearance (GO:0034383) | 2.80191563 |
| 125 | porphyrin-containing compound metabolic process (GO:0006778) | 2.79529121 |
| 126 | fatty acid oxidation (GO:0019395) | 2.79049386 |
| 127 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.77756510 |
| 128 | positive regulation of mast cell degranulation (GO:0043306) | 2.77756510 |
| 129 | carnitine metabolic process (GO:0009437) | 2.77290001 |
| 130 | response to interleukin-15 (GO:0070672) | 2.77145000 |
| 131 | negative regulation of T cell mediated immunity (GO:0002710) | 2.76085904 |
| 132 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.75107499 |
| 133 | regulation of complement activation (GO:0030449) | 2.74864929 |
| 134 | lipid oxidation (GO:0034440) | 2.74656896 |
| 135 | necroptotic process (GO:0070266) | 2.74457861 |
| 136 | regulation of cholesterol esterification (GO:0010872) | 2.74064227 |
| 137 | negative regulation of fibrinolysis (GO:0051918) | 2.74031334 |
| 138 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.73269274 |
| 139 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.72939327 |
| 140 | negative regulation of phagocytosis (GO:0050765) | 2.72134032 |
| 141 | myeloid leukocyte mediated immunity (GO:0002444) | 2.71898304 |
| 142 | definitive hemopoiesis (GO:0060216) | 2.71748008 |
| 143 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.70720081 |
| 144 | immunoglobulin mediated immune response (GO:0016064) | 2.70306286 |
| 145 | myeloid cell development (GO:0061515) | 2.69319146 |
| 146 | thrombin receptor signaling pathway (GO:0070493) | 2.69269876 |
| 147 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.68320521 |
| 148 | regulation of B cell differentiation (GO:0045577) | 2.66703131 |
| 149 | dendritic cell migration (GO:0036336) | 2.66310747 |
| 150 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.66249687 |
| 151 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.66249687 |
| 152 | defense response to fungus (GO:0050832) | 2.64702869 |
| 153 | NADP metabolic process (GO:0006739) | 2.63992369 |
| 154 | drug transmembrane transport (GO:0006855) | 2.63942474 |
| 155 | neutrophil activation involved in immune response (GO:0002283) | 2.63770335 |
| 156 | oxaloacetate metabolic process (GO:0006107) | 2.63629839 |
| 157 | positive regulation of hemostasis (GO:1900048) | 2.63470178 |
| 158 | positive regulation of blood coagulation (GO:0030194) | 2.63470178 |
| 159 | leukocyte aggregation (GO:0070486) | 2.62537588 |
| 160 | positive regulation of macrophage differentiation (GO:0045651) | 2.62060519 |
| 161 | platelet aggregation (GO:0070527) | 2.60527697 |
| 162 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.60506289 |
| 163 | tetrapyrrole biosynthetic process (GO:0033014) | 2.60441317 |
| 164 | peptide catabolic process (GO:0043171) | 2.60221883 |
| 165 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.59657949 |
| 166 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.59483991 |
| 167 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.58480192 |
| 168 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.58295502 |
| 169 | fatty acid catabolic process (GO:0009062) | 2.57994608 |
| 170 | cellular modified amino acid catabolic process (GO:0042219) | 2.57696504 |
| 171 | positive regulation of lipid catabolic process (GO:0050996) | 2.57413453 |
| 172 | myeloid leukocyte activation (GO:0002274) | 2.55861047 |
| 173 | drug transport (GO:0015893) | 2.54864417 |
| 174 | oxygen transport (GO:0015671) | 2.54672975 |
| 175 | regulation of regulated secretory pathway (GO:1903305) | 2.53666410 |
| 176 | mannose metabolic process (GO:0006013) | 2.53640755 |
| 177 | regulation of cholesterol storage (GO:0010885) | 2.53307598 |
| 178 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.53258800 |
| 179 | regulation of cholesterol metabolic process (GO:0090181) | 2.53002362 |
| 180 | dendritic cell chemotaxis (GO:0002407) | 2.52963034 |
| 181 | regulation of regulatory T cell differentiation (GO:0045589) | 2.52819346 |
| 182 | bile acid metabolic process (GO:0008206) | 2.51263515 |
| 183 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.51192227 |
| 184 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.51039440 |
| 185 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.50955850 |
| 186 | urate metabolic process (GO:0046415) | 2.50491431 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.31800526 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.10883416 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.54371626 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.45067800 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.38615077 |
| 6 | GATA1_22025678_ChIP-Seq_K562_Human | 3.38288143 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.25693343 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.09566264 |
| 9 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.91614087 |
| 10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.90366478 |
| 11 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.83188980 |
| 12 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.73632228 |
| 13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.59568889 |
| 14 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.59485436 |
| 15 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.48497572 |
| 16 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.30444780 |
| 17 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.28917646 |
| 18 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.28196548 |
| 19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.25528740 |
| 20 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.24725373 |
| 21 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.19374641 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.09980025 |
| 23 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.08342818 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.06209240 |
| 25 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.02192904 |
| 26 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.99090928 |
| 27 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.91945138 |
| 28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.91403134 |
| 29 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.87084592 |
| 30 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.85590176 |
| 31 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.83367085 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.82037595 |
| 33 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.80076201 |
| 34 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.77946467 |
| 35 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.76396219 |
| 36 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.75883389 |
| 37 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.73220343 |
| 38 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.71909348 |
| 39 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.67203771 |
| 40 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.66139351 |
| 41 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.65978595 |
| 42 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.65545117 |
| 43 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.65297577 |
| 44 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.64805062 |
| 45 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.64565345 |
| 46 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.63457322 |
| 47 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.62907627 |
| 48 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.62029422 |
| 49 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.60886481 |
| 50 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.57200810 |
| 51 | MYB_26560356_Chip-Seq_TH2_Human | 1.51275683 |
| 52 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.50188886 |
| 53 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.46941176 |
| 54 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.43402607 |
| 55 | MYC_22102868_ChIP-Seq_BL_Human | 1.36892183 |
| 56 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.36196766 |
| 57 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.36150549 |
| 58 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34774062 |
| 59 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.34426452 |
| 60 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34228167 |
| 61 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.33834554 |
| 62 | MAF_26560356_Chip-Seq_TH1_Human | 1.33560205 |
| 63 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.32577341 |
| 64 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32471346 |
| 65 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.31514046 |
| 66 | MYB_26560356_Chip-Seq_TH1_Human | 1.31426473 |
| 67 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.31008920 |
| 68 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.29535166 |
| 69 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.26012417 |
| 70 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.25237740 |
| 71 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.24396025 |
| 72 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23959707 |
| 73 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.23280000 |
| 74 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.17364216 |
| 75 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.17237921 |
| 76 | UTX_26944678_Chip-Seq_JUKART_Human | 1.16559857 |
| 77 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.16405425 |
| 78 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.16044789 |
| 79 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12968153 |
| 80 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12817814 |
| 81 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.12332458 |
| 82 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12029093 |
| 83 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11458423 |
| 84 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.09209632 |
| 85 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.08228279 |
| 86 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.05440540 |
| 87 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.05030925 |
| 88 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.04506153 |
| 89 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.04340055 |
| 90 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04036410 |
| 91 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03460601 |
| 92 | SPI1_23127762_ChIP-Seq_K562_Human | 1.03427554 |
| 93 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.02781339 |
| 94 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.01996864 |
| 95 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01341616 |
| 96 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.99444239 |
| 97 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.98876098 |
| 98 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.98668758 |
| 99 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.96491538 |
| 100 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.95986052 |
| 101 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.95739298 |
| 102 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92838165 |
| 103 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.92217814 |
| 104 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.92058926 |
| 105 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.91343118 |
| 106 | GATA3_26560356_Chip-Seq_TH2_Human | 0.91207037 |
| 107 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.90934364 |
| 108 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90893832 |
| 109 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.90485897 |
| 110 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.90334506 |
| 111 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90264889 |
| 112 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.90257255 |
| 113 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.89597750 |
| 114 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87943146 |
| 115 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.86793815 |
| 116 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.86612188 |
| 117 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86437522 |
| 118 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.86373710 |
| 119 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86290339 |
| 120 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.85783127 |
| 121 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.85340521 |
| 122 | MAF_26560356_Chip-Seq_TH2_Human | 0.85203360 |
| 123 | * ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.84749334 |
| 124 | * KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.83456297 |
| 125 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83145629 |
| 126 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.81420905 |
| 127 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81331735 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 3.98764498 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.82082642 |
| 3 | MP0003656_abnormal_erythrocyte_physiolo | 3.54580685 |
| 4 | MP0005365_abnormal_bile_salt | 3.11480376 |
| 5 | MP0004147_increased_porphyrin_level | 3.04514400 |
| 6 | MP0003191_abnormal_cellular_cholesterol | 2.93888942 |
| 7 | MP0009840_abnormal_foam_cell | 2.76545992 |
| 8 | MP0005085_abnormal_gallbladder_physiolo | 2.74532294 |
| 9 | MP0008260_abnormal_autophagy | 2.59843555 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.50178261 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.46256015 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.41344005 |
| 13 | MP0005464_abnormal_platelet_physiology | 2.26859056 |
| 14 | MP0003828_pulmonary_edema | 2.25299122 |
| 15 | MP0005451_abnormal_body_composition | 2.23519535 |
| 16 | MP0008004_abnormal_stomach_pH | 2.14326290 |
| 17 | MP0003300_gastrointestinal_ulcer | 2.03169185 |
| 18 | MP0002166_altered_tumor_susceptibility | 1.98202927 |
| 19 | MP0002396_abnormal_hematopoietic_system | 1.97783280 |
| 20 | MP0001835_abnormal_antigen_presentation | 1.97762541 |
| 21 | MP0000465_gastrointestinal_hemorrhage | 1.92490973 |
| 22 | MP0001666_abnormal_nutrient_absorption | 1.89407098 |
| 23 | MP0003806_abnormal_nucleotide_metabolis | 1.84779552 |
| 24 | MP0003252_abnormal_bile_duct | 1.83501960 |
| 25 | MP0003172_abnormal_lysosome_physiology | 1.83169317 |
| 26 | MP0002419_abnormal_innate_immunity | 1.75963675 |
| 27 | MP0003436_decreased_susceptibility_to | 1.74402995 |
| 28 | MP0000609_abnormal_liver_physiology | 1.73951118 |
| 29 | MP0002132_abnormal_respiratory_system | 1.68620741 |
| 30 | MP0003763_abnormal_thymus_physiology | 1.54696966 |
| 31 | MP0003186_abnormal_redox_activity | 1.54438107 |
| 32 | MP0005332_abnormal_amino_acid | 1.54334842 |
| 33 | MP0000858_altered_metastatic_potential | 1.51436324 |
| 34 | MP0005083_abnormal_biliary_tract | 1.48591626 |
| 35 | MP0005025_abnormal_response_to | 1.46011741 |
| 36 | MP0002006_tumorigenesis | 1.44792779 |
| 37 | MP0003303_peritoneal_inflammation | 1.43817283 |
| 38 | MP0005319_abnormal_enzyme/_coenzyme | 1.43112933 |
| 39 | MP0009643_abnormal_urine_homeostasis | 1.42660935 |
| 40 | MP0005397_hematopoietic_system_phenotyp | 1.41644638 |
| 41 | MP0001545_abnormal_hematopoietic_system | 1.41644638 |
| 42 | MP0009785_altered_susceptibility_to | 1.41470838 |
| 43 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.41189683 |
| 44 | MP0004883_abnormal_blood_vessel | 1.41132583 |
| 45 | MP0006054_spinal_hemorrhage | 1.40279764 |
| 46 | MP0009764_decreased_sensitivity_to | 1.39481452 |
| 47 | MP0002118_abnormal_lipid_homeostasis | 1.39473886 |
| 48 | MP0000685_abnormal_immune_system | 1.38205376 |
| 49 | MP0008469_abnormal_protein_level | 1.37005522 |
| 50 | MP0003183_abnormal_peptide_metabolism | 1.33622488 |
| 51 | MP0001853_heart_inflammation | 1.31710592 |
| 52 | MP0003866_abnormal_defecation | 1.31292721 |
| 53 | MP0004130_abnormal_muscle_cell | 1.31020178 |
| 54 | MP0001873_stomach_inflammation | 1.29681050 |
| 55 | MP0001851_eye_inflammation | 1.29311176 |
| 56 | MP0001764_abnormal_homeostasis | 1.26693002 |
| 57 | MP0002138_abnormal_hepatobiliary_system | 1.26069763 |
| 58 | MP0004510_myositis | 1.24943277 |
| 59 | MP0001845_abnormal_inflammatory_respons | 1.24748920 |
| 60 | MP0009278_abnormal_bone_marrow | 1.23268337 |
| 61 | MP0000598_abnormal_liver_morphology | 1.23068750 |
| 62 | MP0000604_amyloidosis | 1.23031532 |
| 63 | MP0005164_abnormal_response_to | 1.22681801 |
| 64 | MP0009333_abnormal_splenocyte_physiolog | 1.21895232 |
| 65 | MP0002998_abnormal_bone_remodeling | 1.20143750 |
| 66 | MP0002452_abnormal_antigen_presenting | 1.19514210 |
| 67 | MP0003724_increased_susceptibility_to | 1.18829954 |
| 68 | MP0000015_abnormal_ear_pigmentation | 1.18505158 |
| 69 | MP0005636_abnormal_mineral_homeostasis | 1.17940624 |
| 70 | MP0010352_gastrointestinal_tract_polyps | 1.17442043 |
| 71 | MP0004808_abnormal_hematopoietic_stem | 1.16227034 |
| 72 | MP0000689_abnormal_spleen_morphology | 1.15746772 |
| 73 | MP0005310_abnormal_salivary_gland | 1.15726188 |
| 74 | MP0010155_abnormal_intestine_physiology | 1.15403808 |
| 75 | MP0010307_abnormal_tumor_latency | 1.14866647 |
| 76 | MP0002398_abnormal_bone_marrow | 1.14304533 |
| 77 | MP0001800_abnormal_humoral_immune | 1.13529465 |
| 78 | MP0002420_abnormal_adaptive_immunity | 1.11170812 |
| 79 | MP0002723_abnormal_immune_serum | 1.10403002 |
| 80 | MP0001819_abnormal_immune_cell | 1.10385553 |
| 81 | MP0004381_abnormal_hair_follicle | 1.08792478 |
| 82 | MP0000703_abnormal_thymus_morphology | 1.08527973 |
| 83 | MP0009763_increased_sensitivity_to | 1.07132350 |
| 84 | MP0004264_abnormal_extraembryonic_tissu | 1.07111447 |
| 85 | MP0002722_abnormal_immune_system | 1.06933117 |
| 86 | MP0005387_immune_system_phenotype | 1.06822193 |
| 87 | MP0001790_abnormal_immune_system | 1.06822193 |
| 88 | MP0000569_abnormal_digit_pigmentation | 1.05209088 |
| 89 | MP0009697_abnormal_copulation | 1.04372642 |
| 90 | MP0005000_abnormal_immune_tolerance | 1.04200797 |
| 91 | MP0010234_abnormal_vibrissa_follicle | 1.03369605 |
| 92 | MP0002405_respiratory_system_inflammati | 1.03263911 |
| 93 | MP0002429_abnormal_blood_cell | 1.01922095 |
| 94 | MP0005671_abnormal_response_to | 1.01675529 |
| 95 | MP0000716_abnormal_immune_system | 1.00299231 |
| 96 | MP0004019_abnormal_vitamin_homeostasis | 0.99320330 |
| 97 | MP0000249_abnormal_blood_vessel | 0.99084242 |
| 98 | MP0000343_altered_response_to | 0.98659699 |
| 99 | MP0005409_darkened_coat_color | 0.98019102 |
| 100 | MP0003221_abnormal_cardiomyocyte_apopto | 0.96328059 |
| 101 | MP0004947_skin_inflammation | 0.95903572 |
| 102 | MP0002148_abnormal_hypersensitivity_rea | 0.94175261 |
| 103 | MP0001533_abnormal_skeleton_physiology | 0.93059371 |
| 104 | MP0001756_abnormal_urination | 0.92870507 |
| 105 | MP0004484_altered_response_of | 0.92783401 |
| 106 | MP0003091_abnormal_cell_migration | 0.91988929 |
| 107 | MP0002877_abnormal_melanocyte_morpholog | 0.91837105 |
| 108 | MP0005167_abnormal_blood-brain_barrier | 0.91288292 |
| 109 | MP0002136_abnormal_kidney_physiology | 0.90425412 |
| 110 | MP0002971_abnormal_brown_adipose | 0.89389401 |
| 111 | MP0003075_altered_response_to | 0.88465115 |
| 112 | MP0009765_abnormal_xenobiotic_induced | 0.87129729 |
| 113 | MP0004185_abnormal_adipocyte_glucose | 0.86886089 |
| 114 | MP0003448_altered_tumor_morphology | 0.86442638 |
| 115 | MP0003868_abnormal_feces_composition | 0.86185010 |
| 116 | MP0003690_abnormal_glial_cell | 0.84870619 |
| 117 | MP0003705_abnormal_hypodermis_morpholog | 0.84722456 |
| 118 | MP0000490_abnormal_crypts_of | 0.84336301 |
| 119 | MP0005647_abnormal_sex_gland | 0.83903406 |
| 120 | MP0003566_abnormal_cell_adhesion | 0.80999821 |
| 121 | MP0005666_abnormal_adipose_tissue | 0.80941824 |
| 122 | MP0005166_decreased_susceptibility_to | 0.80913628 |
| 123 | MP0006036_abnormal_mitochondrial_physio | 0.80808068 |
| 124 | MP0003453_abnormal_keratinocyte_physiol | 0.80239952 |
| 125 | MP0001915_intracranial_hemorrhage | 0.79741672 |
| 126 | MP0009115_abnormal_fat_cell | 0.79664216 |
| 127 | MP0002254_reproductive_system_inflammat | 0.78140618 |
| 128 | MP0008874_decreased_physiological_sensi | 0.78133651 |
| 129 | MP0006082_CNS_inflammation | 0.77484855 |
| 130 | MP0003195_calcinosis | 0.77127303 |
| 131 | MP0009642_abnormal_blood_homeostasis | 0.76721912 |
| 132 | MP0002332_abnormal_exercise_endurance | 0.74953647 |
| 133 | MP0001663_abnormal_digestive_system | 0.72958547 |
| 134 | MP0003795_abnormal_bone_structure | 0.66411791 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Poikilocytosis (HP:0004447) | 4.60172143 |
| 2 | Acanthocytosis (HP:0001927) | 4.16341495 |
| 3 | Deep venous thrombosis (HP:0002625) | 3.67756268 |
| 4 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.57606890 |
| 5 | Orchitis (HP:0100796) | 3.56721369 |
| 6 | Hypochromic microcytic anemia (HP:0004840) | 3.43133357 |
| 7 | Gastrointestinal infarctions (HP:0005244) | 3.43122124 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 3.41901515 |
| 9 | Optic neuritis (HP:0100653) | 3.41901515 |
| 10 | Xanthomatosis (HP:0000991) | 3.39726702 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.32174936 |
| 12 | Vacuolated lymphocytes (HP:0001922) | 3.29966362 |
| 13 | Petechiae (HP:0000967) | 3.29067663 |
| 14 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.23378227 |
| 15 | Hypobetalipoproteinemia (HP:0003563) | 3.23107890 |
| 16 | Complement deficiency (HP:0004431) | 3.19721021 |
| 17 | Intrahepatic cholestasis (HP:0001406) | 3.16918547 |
| 18 | Obstructive lung disease (HP:0006536) | 3.12208332 |
| 19 | Chronic obstructive pulmonary disease (HP:0006510) | 3.12208332 |
| 20 | Thrombocytosis (HP:0001894) | 3.10730094 |
| 21 | Abnormal platelet volume (HP:0011876) | 3.09300606 |
| 22 | Recurrent bacterial skin infections (HP:0005406) | 3.09082513 |
| 23 | Stomatitis (HP:0010280) | 3.09082143 |
| 24 | Increased mean platelet volume (HP:0011877) | 3.08914542 |
| 25 | Gingival bleeding (HP:0000225) | 3.08680656 |
| 26 | Increased cerebral lipofuscin (HP:0011813) | 3.04423406 |
| 27 | Recurrent abscess formation (HP:0002722) | 3.03688372 |
| 28 | Abnormality of the common coagulation pathway (HP:0010990) | 3.03335244 |
| 29 | Hyperbilirubinemia (HP:0002904) | 2.99489878 |
| 30 | Arterial thrombosis (HP:0004420) | 2.95519329 |
| 31 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.94005861 |
| 32 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.87157056 |
| 33 | Gingivitis (HP:0000230) | 2.85892485 |
| 34 | Autoimmune thrombocytopenia (HP:0001973) | 2.85261858 |
| 35 | Abnormal platelet function (HP:0011869) | 2.83183300 |
| 36 | Impaired platelet aggregation (HP:0003540) | 2.83183300 |
| 37 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.81234542 |
| 38 | T lymphocytopenia (HP:0005403) | 2.79250695 |
| 39 | Eczematoid dermatitis (HP:0000976) | 2.79133559 |
| 40 | Cholelithiasis (HP:0001081) | 2.77245984 |
| 41 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.77158439 |
| 42 | Joint hemorrhage (HP:0005261) | 2.76250072 |
| 43 | Epistaxis (HP:0000421) | 2.74370174 |
| 44 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.74341288 |
| 45 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.71783774 |
| 46 | Encephalitis (HP:0002383) | 2.71440833 |
| 47 | Keratoconjunctivitis sicca (HP:0001097) | 2.71377309 |
| 48 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.70981097 |
| 49 | Chest pain (HP:0100749) | 2.70907243 |
| 50 | Prolonged bleeding time (HP:0003010) | 2.70114811 |
| 51 | Abnormality of the intrinsic pathway (HP:0010989) | 2.67813642 |
| 52 | Hyperammonemia (HP:0001987) | 2.66269906 |
| 53 | Abnormality of T cell number (HP:0011839) | 2.62337163 |
| 54 | Purpura (HP:0000979) | 2.60266725 |
| 55 | Abnormal gallbladder morphology (HP:0012437) | 2.59772109 |
| 56 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.59118405 |
| 57 | Mucopolysacchariduria (HP:0008155) | 2.59118405 |
| 58 | Prolonged partial thromboplastin time (HP:0003645) | 2.58725147 |
| 59 | Systemic lupus erythematosus (HP:0002725) | 2.58263345 |
| 60 | Hypoglycemic coma (HP:0001325) | 2.56139277 |
| 61 | Meningitis (HP:0001287) | 2.53540313 |
| 62 | Menorrhagia (HP:0000132) | 2.51859156 |
| 63 | Vasculitis (HP:0002633) | 2.51190312 |
| 64 | Hypolipoproteinemia (HP:0010981) | 2.50511286 |
| 65 | Ketosis (HP:0001946) | 2.50144527 |
| 66 | Recurrent viral infections (HP:0004429) | 2.49544384 |
| 67 | Fat malabsorption (HP:0002630) | 2.49096520 |
| 68 | Hyperlipoproteinemia (HP:0010980) | 2.48775437 |
| 69 | Conjunctival telangiectasia (HP:0000524) | 2.48170978 |
| 70 | Spontaneous hematomas (HP:0007420) | 2.47920222 |
| 71 | IgM deficiency (HP:0002850) | 2.47595424 |
| 72 | Myocardial infarction (HP:0001658) | 2.47560786 |
| 73 | Abnormality of macrophages (HP:0004311) | 2.47438292 |
| 74 | Episodic fever (HP:0001954) | 2.44497260 |
| 75 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.43201489 |
| 76 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.43090002 |
| 77 | Keratoconjunctivitis (HP:0001096) | 2.41065685 |
| 78 | Peritonitis (HP:0002586) | 2.41004607 |
| 79 | Pulmonary embolism (HP:0002204) | 2.37107998 |
| 80 | Mediastinal lymphadenopathy (HP:0100721) | 2.36415039 |
| 81 | Dysostosis multiplex (HP:0000943) | 2.35003685 |
| 82 | Thrombophlebitis (HP:0004418) | 2.34679613 |
| 83 | Hyperglycinuria (HP:0003108) | 2.34470216 |
| 84 | Cellulitis (HP:0100658) | 2.33522125 |
| 85 | Leukocytosis (HP:0001974) | 2.32784494 |
| 86 | Abnormality of complement system (HP:0005339) | 2.30670533 |
| 87 | Hypercholesterolemia (HP:0003124) | 2.29390277 |
| 88 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.27333531 |
| 89 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.27333531 |
| 90 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.27333531 |
| 91 | Recurrent skin infections (HP:0001581) | 2.26324465 |
| 92 | Bruising susceptibility (HP:0000978) | 2.25763238 |
| 93 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.25744048 |
| 94 | Amyloidosis (HP:0011034) | 2.24307486 |
| 95 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.23345349 |
| 96 | Reticulocytosis (HP:0001923) | 2.23337392 |
| 97 | Inflammation of the large intestine (HP:0002037) | 2.21817245 |
| 98 | Epidermoid cyst (HP:0200040) | 2.21681987 |
| 99 | Abnormality of glycine metabolism (HP:0010895) | 2.21512439 |
| 100 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.21512439 |
| 101 | Osteomyelitis (HP:0002754) | 2.21050533 |
| 102 | Recurrent fungal infections (HP:0002841) | 2.20539157 |
| 103 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.18345767 |
| 104 | Recurrent cutaneous fungal infections (HP:0011370) | 2.18345767 |
| 105 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.18312950 |
| 106 | Autoimmune hemolytic anemia (HP:0001890) | 2.16762975 |
| 107 | Hypochromic anemia (HP:0001931) | 2.16757934 |
| 108 | Hepatosplenomegaly (HP:0001433) | 2.16225343 |
| 109 | Hepatocellular carcinoma (HP:0001402) | 2.15764755 |
| 110 | Hypertriglyceridemia (HP:0002155) | 2.15742978 |
| 111 | Periodontitis (HP:0000704) | 2.15720552 |
| 112 | Joint swelling (HP:0001386) | 2.14406722 |
| 113 | Increased serum ferritin (HP:0003281) | 2.13789736 |
| 114 | Microcytic anemia (HP:0001935) | 2.13413541 |
| 115 | Hypoalphalipoproteinemia (HP:0003233) | 2.10574989 |
| 116 | Nausea (HP:0002018) | 2.10077205 |
| 117 | Hemoptysis (HP:0002105) | 2.08997981 |
| 118 | Polycythemia (HP:0001901) | 2.08920694 |
| 119 | Pulmonary infiltrates (HP:0002113) | 2.08330648 |
| 120 | Gastrointestinal inflammation (HP:0004386) | 2.08261518 |
| 121 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.07713138 |
| 122 | Urticaria (HP:0001025) | 2.06790301 |
| 123 | Abnormality of purine metabolism (HP:0004352) | 2.06013579 |
| 124 | Acute hepatic failure (HP:0006554) | 2.05938284 |
| 125 | Myositis (HP:0100614) | 2.05583356 |
| 126 | Abnormality of iron homeostasis (HP:0011031) | 2.05375884 |
| 127 | Granulocytopenia (HP:0001913) | 2.04424692 |
| 128 | Anorexia (HP:0002039) | 2.04400847 |
| 129 | Steatorrhea (HP:0002570) | 2.03947789 |
| 130 | Abnormal gallbladder physiology (HP:0012438) | 2.03603222 |
| 131 | Cholecystitis (HP:0001082) | 2.03603222 |
| 132 | Increased IgE level (HP:0003212) | 2.03213254 |
| 133 | Generalized aminoaciduria (HP:0002909) | 2.02511915 |
| 134 | Spastic diplegia (HP:0001264) | 2.02156930 |
| 135 | Hematochezia (HP:0002573) | 2.01151736 |
| 136 | Abnormality of the gallbladder (HP:0005264) | 2.00687832 |
| 137 | Pustule (HP:0200039) | 2.00108109 |
| 138 | Fatigue (HP:0012378) | 1.99753279 |
| 139 | Gangrene (HP:0100758) | 1.99625306 |
| 140 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.99437956 |
| 141 | Spontaneous abortion (HP:0005268) | 1.98691679 |
| 142 | Chronic otitis media (HP:0000389) | 1.98212645 |
| 143 | Abnormality of nucleobase metabolism (HP:0010932) | 1.98027078 |
| 144 | Glomerulopathy (HP:0100820) | 1.95724883 |
| 145 | Nonimmune hydrops fetalis (HP:0001790) | 1.95165410 |
| 146 | Abnormality of T cells (HP:0002843) | 1.93935140 |
| 147 | Metabolic acidosis (HP:0001942) | 1.92832056 |
| 148 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.90374664 |
| 149 | Osteolytic defects of the hand bones (HP:0009699) | 1.90374664 |
| 150 | Vertigo (HP:0002321) | 1.90312751 |
| 151 | Paralysis (HP:0003470) | 1.89641232 |
| 152 | Hydroxyprolinuria (HP:0003080) | 1.89490084 |
| 153 | Increased IgM level (HP:0003496) | 1.88046394 |
| 154 | Slow saccadic eye movements (HP:0000514) | 1.82317615 |
| 155 | Colitis (HP:0002583) | 1.80351332 |
| 156 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.79490689 |
| 157 | Abnormality of glycolipid metabolism (HP:0010969) | 1.79490689 |
| 158 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.79490689 |
| 159 | Subacute progressive viral hepatitis (HP:0006572) | 1.77630357 |
| 160 | Eosinophilia (HP:0001880) | 1.76384355 |
| 161 | Viral hepatitis (HP:0006562) | 1.75455299 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 5.01799423 |
| 2 | TAOK3 | 3.62992854 |
| 3 | EEF2K | 2.83686136 |
| 4 | ERN1 | 2.68557585 |
| 5 | TRIB3 | 2.59224430 |
| 6 | MAP4K1 | 2.55700307 |
| 7 | BCKDK | 2.53721305 |
| 8 | PKN2 | 2.51830397 |
| 9 | KIT | 2.25861232 |
| 10 | FLT3 | 2.25410492 |
| 11 | PRPF4B | 2.25054905 |
| 12 | STK10 | 2.23640835 |
| 13 | SCYL2 | 2.21331109 |
| 14 | FGR | 2.06250194 |
| 15 | TYK2 | 2.02587029 |
| 16 | NEK9 | 1.97058680 |
| 17 | EIF2AK1 | 1.95158992 |
| 18 | BMPR2 | 1.94515646 |
| 19 | FRK | 1.90571879 |
| 20 | JAK3 | 1.82419476 |
| 21 | LRRK2 | 1.72300677 |
| 22 | CAMK1D | 1.70265398 |
| 23 | OXSR1 | 1.67102752 |
| 24 | BTK | 1.65366051 |
| 25 | TGFBR2 | 1.61627966 |
| 26 | MAP2K3 | 1.58670239 |
| 27 | KSR2 | 1.56249657 |
| 28 | EPHB1 | 1.54662690 |
| 29 | CSF1R | 1.47926451 |
| 30 | FGFR4 | 1.39238485 |
| 31 | MAP3K1 | 1.39223261 |
| 32 | TEC | 1.37462442 |
| 33 | BMX | 1.36750095 |
| 34 | STK39 | 1.36394329 |
| 35 | IRAK4 | 1.34616744 |
| 36 | MAPK11 | 1.31972131 |
| 37 | YES1 | 1.30885176 |
| 38 | JAK2 | 1.29659966 |
| 39 | TBK1 | 1.29444635 |
| 40 | PTK2B | 1.28607206 |
| 41 | TAOK1 | 1.28405281 |
| 42 | ZAP70 | 1.25702970 |
| 43 | BRSK2 | 1.22077684 |
| 44 | TRPM7 | 1.22008373 |
| 45 | MAPKAPK3 | 1.19852106 |
| 46 | SYK | 1.18544193 |
| 47 | JAK1 | 1.18437475 |
| 48 | SIK1 | 1.18132914 |
| 49 | RIPK1 | 1.17448267 |
| 50 | MST4 | 1.16868433 |
| 51 | MATK | 1.15592874 |
| 52 | GRK6 | 1.14257092 |
| 53 | STK4 | 1.11510423 |
| 54 | MAP3K5 | 1.09929703 |
| 55 | TAOK2 | 1.09460379 |
| 56 | PTK6 | 1.06389803 |
| 57 | TGFBR1 | 1.04274577 |
| 58 | IRAK1 | 1.01383068 |
| 59 | MAP3K8 | 1.00036059 |
| 60 | CDK6 | 0.99595502 |
| 61 | TNK2 | 0.97474187 |
| 62 | MAP3K11 | 0.95921466 |
| 63 | PIM1 | 0.93914337 |
| 64 | MAP3K14 | 0.92309694 |
| 65 | PIK3CG | 0.91586006 |
| 66 | TTN | 0.91019454 |
| 67 | SGK2 | 0.88754512 |
| 68 | ITK | 0.85930758 |
| 69 | IKBKE | 0.85902327 |
| 70 | BLK | 0.85839873 |
| 71 | FES | 0.84369178 |
| 72 | MAP3K13 | 0.84356540 |
| 73 | PRKAA2 | 0.83555956 |
| 74 | EPHA3 | 0.82904392 |
| 75 | FGFR3 | 0.82752075 |
| 76 | CSK | 0.82608820 |
| 77 | RPS6KB2 | 0.81958386 |
| 78 | MARK3 | 0.81873939 |
| 79 | MAP3K6 | 0.81207372 |
| 80 | WNK1 | 0.76147235 |
| 81 | PAK4 | 0.74832435 |
| 82 | GRK5 | 0.74527095 |
| 83 | LMTK2 | 0.73841839 |
| 84 | PDK3 | 0.73005313 |
| 85 | PDK4 | 0.73005313 |
| 86 | ACVR1B | 0.69955504 |
| 87 | PDK1 | 0.69509282 |
| 88 | DYRK1B | 0.69420397 |
| 89 | STK3 | 0.68868053 |
| 90 | KSR1 | 0.68751387 |
| 91 | CDC7 | 0.67935803 |
| 92 | CAMKK2 | 0.66251571 |
| 93 | LYN | 0.65849468 |
| 94 | MARK2 | 0.64912193 |
| 95 | IRAK2 | 0.64089167 |
| 96 | CAMK1G | 0.63761097 |
| 97 | LCK | 0.63472096 |
| 98 | TESK2 | 0.62336764 |
| 99 | RET | 0.61116849 |
| 100 | MAPK12 | 0.59843195 |
| 101 | NEK2 | 0.59797991 |
| 102 | CDK12 | 0.58813734 |
| 103 | CDK4 | 0.58558613 |
| 104 | MAPKAPK5 | 0.58501138 |
| 105 | KDR | 0.57987382 |
| 106 | IRAK3 | 0.54726391 |
| 107 | FYN | 0.54281699 |
| 108 | HCK | 0.51063967 |
| 109 | HIPK2 | 0.49682990 |
| 110 | TIE1 | 0.49237902 |
| 111 | PDPK1 | 0.49177456 |
| 112 | PDK2 | 0.48861630 |
| 113 | PIM2 | 0.48855724 |
| 114 | NLK | 0.48599444 |
| 115 | EIF2AK3 | 0.46765608 |
| 116 | CDK9 | 0.46717298 |
| 117 | WEE1 | 0.44661096 |
| 118 | IKBKB | 0.43986257 |
| 119 | MYLK | 0.43530480 |
| 120 | ERBB2 | 0.42799933 |
| 121 | SIK3 | 0.41561890 |
| 122 | RPS6KA6 | 0.41412437 |
| 123 | PDGFRB | 0.41304124 |
| 124 | MAPK4 | 0.40035385 |
| 125 | MAP3K2 | 0.39650829 |
| 126 | CHUK | 0.39202203 |
| 127 | MAP3K3 | 0.38746714 |
| 128 | MAP2K4 | 0.37798991 |
| 129 | TXK | 0.37289702 |
| 130 | RPS6KA4 | 0.36974684 |
| 131 | EGFR | 0.36654682 |
| 132 | STK24 | 0.36526942 |
| 133 | RAF1 | 0.35849185 |
| 134 | MAPKAPK2 | 0.35559077 |
| 135 | PRKD1 | 0.35192808 |
| 136 | SGK3 | 0.34615549 |
| 137 | PRKCQ | 0.32464257 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.21558569 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.79065800 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.52649287 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47503524 |
| 5 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.26665315 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.16659007 |
| 7 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.16383774 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.16337959 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.10587478 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.99615852 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.99612590 |
| 12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.99217425 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.96887493 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.95854955 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.91834740 |
| 16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.87480516 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.83993355 |
| 18 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.83775721 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.80373025 |
| 20 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.78248533 |
| 21 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.76418648 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 1.73133401 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.71823705 |
| 24 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.71405695 |
| 25 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.65673913 |
| 26 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.62027994 |
| 27 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.61976040 |
| 28 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.57206067 |
| 29 | Other glycan degradation_Homo sapiens_hsa00511 | 1.56230147 |
| 30 | ABC transporters_Homo sapiens_hsa02010 | 1.53553123 |
| 31 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.47222138 |
| 32 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.45741906 |
| 33 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.43803613 |
| 34 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.43245533 |
| 35 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.42979773 |
| 36 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.42092403 |
| 37 | Carbon metabolism_Homo sapiens_hsa01200 | 1.39446494 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.39000439 |
| 39 | Phagosome_Homo sapiens_hsa04145 | 1.35432924 |
| 40 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.34746218 |
| 41 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.33874520 |
| 42 | Histidine metabolism_Homo sapiens_hsa00340 | 1.33589391 |
| 43 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.31650260 |
| 44 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.31274862 |
| 45 | Allograft rejection_Homo sapiens_hsa05330 | 1.28645261 |
| 46 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.27727431 |
| 47 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.25243371 |
| 48 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.23808764 |
| 49 | Lysosome_Homo sapiens_hsa04142 | 1.21877090 |
| 50 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.19346943 |
| 51 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.18832438 |
| 52 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.17520505 |
| 53 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.17417794 |
| 54 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.16873555 |
| 55 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.13492946 |
| 56 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.13158349 |
| 57 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.11549097 |
| 58 | Hepatitis B_Homo sapiens_hsa05161 | 1.09770997 |
| 59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.09469848 |
| 60 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.07258019 |
| 61 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.04952987 |
| 62 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.03334668 |
| 63 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.03113258 |
| 64 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.00540887 |
| 65 | Shigellosis_Homo sapiens_hsa05131 | 1.00233304 |
| 66 | Endometrial cancer_Homo sapiens_hsa05213 | 0.99787588 |
| 67 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.96106412 |
| 68 | Leishmaniasis_Homo sapiens_hsa05140 | 0.95064702 |
| 69 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.93502105 |
| 70 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.93345274 |
| 71 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.91639097 |
| 72 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.90107453 |
| 73 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.89891917 |
| 74 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.89596918 |
| 75 | Viral myocarditis_Homo sapiens_hsa05416 | 0.86726080 |
| 76 | Amoebiasis_Homo sapiens_hsa05146 | 0.86667488 |
| 77 | Bile secretion_Homo sapiens_hsa04976 | 0.85798866 |
| 78 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.84978454 |
| 79 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.84822043 |
| 80 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.84803076 |
| 81 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.84185949 |
| 82 | Endocytosis_Homo sapiens_hsa04144 | 0.83601647 |
| 83 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.83502005 |
| 84 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.83448790 |
| 85 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.83135980 |
| 86 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.82159442 |
| 87 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.81254505 |
| 88 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.81063955 |
| 89 | Salmonella infection_Homo sapiens_hsa05132 | 0.80958560 |
| 90 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.80299339 |
| 91 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.79190223 |
| 92 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.78963330 |
| 93 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.78639752 |
| 94 | Lysine degradation_Homo sapiens_hsa00310 | 0.77701590 |
| 95 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.75725663 |
| 96 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.74697321 |
| 97 | Sulfur relay system_Homo sapiens_hsa04122 | 0.73904468 |
| 98 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.73756864 |
| 99 | Asthma_Homo sapiens_hsa05310 | 0.72490204 |
| 100 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.71598220 |
| 101 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.70706465 |
| 102 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.70349333 |
| 103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70167415 |
| 104 | Insulin resistance_Homo sapiens_hsa04931 | 0.69507623 |
| 105 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.67869324 |
| 106 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.67476117 |
| 107 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.66650742 |
| 108 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.66038476 |
| 109 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.65736476 |
| 110 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.65650213 |
| 111 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.64923888 |
| 112 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.64446550 |
| 113 | Galactose metabolism_Homo sapiens_hsa00052 | 0.64065139 |
| 114 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63888078 |
| 115 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.63867327 |
| 116 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.63677707 |
| 117 | Glioma_Homo sapiens_hsa05214 | 0.62629731 |
| 118 | Legionellosis_Homo sapiens_hsa05134 | 0.61731325 |
| 119 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.60059486 |
| 120 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.59397472 |
| 121 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.59213218 |
| 122 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.59030691 |
| 123 | Retinol metabolism_Homo sapiens_hsa00830 | 0.58860994 |
| 124 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.58260324 |
| 125 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.57880507 |
| 126 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.57121534 |
| 127 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.56992262 |
| 128 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.55773397 |
| 129 | Prostate cancer_Homo sapiens_hsa05215 | 0.54621621 |
| 130 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.54405158 |
| 131 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.54307996 |
| 132 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.53263472 |
| 133 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.52636957 |
| 134 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.52372792 |
| 135 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.51974736 |
| 136 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.51321094 |
| 137 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.51009779 |
| 138 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.49874021 |
| 139 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.48965841 |
| 140 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.48905432 |
| 141 | Platelet activation_Homo sapiens_hsa04611 | 0.47984910 |
| 142 | Measles_Homo sapiens_hsa05162 | 0.47831639 |
| 143 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.47412456 |
| 144 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.46817073 |
| 145 | Pertussis_Homo sapiens_hsa05133 | 0.45934439 |
| 146 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.44555853 |
| 147 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.42184784 |
| 148 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.41754571 |
| 149 | Tuberculosis_Homo sapiens_hsa05152 | 0.41264566 |
| 150 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.41084830 |
| 151 | Apoptosis_Homo sapiens_hsa04210 | 0.40733025 |
| 152 | DNA replication_Homo sapiens_hsa03030 | 0.37812340 |
| 153 | Hepatitis C_Homo sapiens_hsa05160 | 0.37740313 |
| 154 | Influenza A_Homo sapiens_hsa05164 | 0.37115463 |
| 155 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.36622363 |
| 156 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.36228420 |
| 157 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.35544995 |
| 158 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.35161228 |
| 159 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.35137288 |
| 160 | Malaria_Homo sapiens_hsa05144 | 0.34743189 |
| 161 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.32972431 |

